GR3003952T3 - - Google Patents

Info

Publication number
GR3003952T3
GR3003952T3 GR920400270T GR920400270T GR3003952T3 GR 3003952 T3 GR3003952 T3 GR 3003952T3 GR 920400270 T GR920400270 T GR 920400270T GR 920400270 T GR920400270 T GR 920400270T GR 3003952 T3 GR3003952 T3 GR 3003952T3
Authority
GR
Greece
Prior art keywords
alkyl
different
same
formula
proviso
Prior art date
Application number
GR920400270T
Other languages
English (en)
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed filed Critical
Publication of GR3003952T3 publication Critical patent/GR3003952T3/el

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A61K31/519—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with heterocyclic rings
    • A61K31/52—Purines, e.g. adenine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D473/00—Heterocyclic compounds containing purine ring systems
    • C07D473/02—Heterocyclic compounds containing purine ring systems with oxygen, sulphur, or nitrogen atoms directly attached in positions 2 and 6
    • C07D473/04—Heterocyclic compounds containing purine ring systems with oxygen, sulphur, or nitrogen atoms directly attached in positions 2 and 6 two oxygen atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D473/00—Heterocyclic compounds containing purine ring systems
    • C07D473/02—Heterocyclic compounds containing purine ring systems with oxygen, sulphur, or nitrogen atoms directly attached in positions 2 and 6
    • C07D473/04—Heterocyclic compounds containing purine ring systems with oxygen, sulphur, or nitrogen atoms directly attached in positions 2 and 6 two oxygen atoms
    • C07D473/06—Heterocyclic compounds containing purine ring systems with oxygen, sulphur, or nitrogen atoms directly attached in positions 2 and 6 two oxygen atoms with radicals containing only hydrogen and carbon atoms, attached in position 1 or 3

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicinal Preparation (AREA)
GR920400270T 1988-02-19 1992-03-04 GR3003952T3 (el)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP63035484A JP2661666B2 (ja) 1988-02-19 1988-02-19 抗消化性潰瘍剤

Publications (1)

Publication Number Publication Date
GR3003952T3 true GR3003952T3 (el) 1993-03-16

Family

ID=12443024

Family Applications (1)

Application Number Title Priority Date Filing Date
GR920400270T GR3003952T3 (el) 1988-02-19 1992-03-04

Country Status (17)

Country Link
US (1) US5082845A (el)
EP (1) EP0330031B1 (el)
JP (1) JP2661666B2 (el)
KR (1) KR0133075B1 (el)
AT (1) ATE70182T1 (el)
AU (1) AU605669B2 (el)
DE (1) DE68900516D1 (el)
DK (1) DK74189A (el)
ES (1) ES2039719T3 (el)
GR (1) GR3003952T3 (el)
HU (1) HU204702B (el)
IE (1) IE61147B1 (el)
IL (1) IL89324A0 (el)
NZ (1) NZ228020A (el)
PH (1) PH27149A (el)
PT (1) PT89757B (el)
ZA (1) ZA891241B (el)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2661666B2 (ja) * 1988-02-19 1997-10-08 ヘキスト薬品工業株式会社 抗消化性潰瘍剤
DD298051A5 (de) * 1989-08-16 1992-02-06 ��@���������@�������k�� Verfahren zur herstellung eines therapeutischen agens zur behandlung von verdauungskrankheiten
IT1240843B (it) * 1990-05-24 1993-12-17 Malesci Istituto Farmacobiologico Derivati xantinici 1-7 sostituiti ad attivita' antiasmatica, loro sali fisiologicamente accettabili, loro composizioni farmaceutiche e procedimento per la loro preparazione.
JP2549480B2 (ja) * 1991-12-10 1996-10-30 ヘキストジャパン株式会社 排尿障害改善剤
EP0570831A2 (de) * 1992-05-20 1993-11-24 Hoechst Aktiengesellschaft Verwendung von Xanthinderivaten zur Behandlung von Nervenschädigungen nach Unterbrechung der Blutzirkulation
US5354756A (en) * 1993-01-12 1994-10-11 Cell Therapeutics, Inc. Olefin-substituted long chain xanthine compounds
US5620676A (en) * 1994-03-08 1997-04-15 The United States Of America As Represented By The Department Of Health And Human Services Biologically active ATP analogs
JP5292413B2 (ja) 2008-02-29 2013-09-18 コンサート ファーマシューティカルズ インコーポレイテッド 置換キサンチン誘導体
US20110053961A1 (en) 2009-02-27 2011-03-03 Concert Pharmaceuticals, Inc. Substituted xanthine derivatives

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CH608236A5 (el) * 1974-01-22 1978-12-29 Wuelfing J A Fa
DE2432702C2 (de) * 1974-07-08 1983-01-20 Hoechst Ag, 6000 Frankfurt Verfahren zur Herstellung von Hydroxyalkylxanthinen
US4207321A (en) * 1977-04-02 1980-06-10 Hoechst Aktiengesellschaft Pharmaceutical compositions containing xanthines
EP0042706B1 (en) * 1980-06-21 1985-12-27 BEECHAM - WUELFING GmbH & Co. KG Xanthine derivatives, pharmaceutical compositions containing them and a process for their preparation
DE3138397A1 (de) * 1981-09-26 1983-04-07 Hoechst Ag, 6230 Frankfurt "arzneimittel, darin enthaltene vicinale dihydroxyalkylxanthine und herstellungsverfahren fuer diese xanthinverbindungen"
US4636507A (en) * 1984-04-30 1987-01-13 Hoechst-Roussel Pharmaceuticals Inc. Host defense mechanism enhancement
GB8418430D0 (en) * 1984-07-19 1984-08-22 Beecham Wuelfing Gmbh & Co Kg Treatment
DE3508097A1 (de) * 1984-07-21 1986-02-06 Hoechst Ag, 6230 Frankfurt Kombinationspraeparat aus xanthinderivaten und o-acetylsalicylsaeure bzw. deren pharmakologisch vertraeglichen salzen und dessen verwendung
DE3525801A1 (de) * 1985-07-19 1987-01-22 Hoechst Ag Tertiaere hydroxyalkylxanthine, verfahren zu ihrer herstellung, die sie enthaltenden arzneimittel und ihre verwendung
US4772607A (en) * 1986-05-20 1988-09-20 Warner-Lambert Company Dialkenyl derivatives of xanthine, pharmaceutical compositions and methods of use therefor
JPS63225317A (ja) * 1986-10-06 1988-09-20 Hoechst Japan Kk 抗消化性潰瘍剤
JP2661666B2 (ja) * 1988-02-19 1997-10-08 ヘキスト薬品工業株式会社 抗消化性潰瘍剤

Also Published As

Publication number Publication date
IL89324A0 (en) 1989-09-10
DK74189A (da) 1989-08-20
AU605669B2 (en) 1991-01-17
KR0133075B1 (ko) 1998-04-17
DK74189D0 (da) 1989-02-17
PT89757B (pt) 1994-03-31
NZ228020A (en) 1991-07-26
DE68900516D1 (de) 1992-01-23
ZA891241B (en) 1989-10-25
HUT49283A (en) 1989-09-28
PT89757A (pt) 1989-10-04
ES2039719T3 (es) 1993-10-01
EP0330031A1 (en) 1989-08-30
KR890012652A (ko) 1989-09-18
JP2661666B2 (ja) 1997-10-08
AU2853889A (en) 1989-08-24
EP0330031B1 (en) 1991-12-11
PH27149A (en) 1993-04-02
US5082845A (en) 1992-01-21
IE890514L (en) 1989-08-19
HU204702B (en) 1992-02-28
IE61147B1 (en) 1994-10-05
ATE70182T1 (de) 1991-12-15
JPH01211524A (ja) 1989-08-24

Similar Documents

Publication Publication Date Title
AU613805B2 (en) Pyrimidinedione derivative compounds, method of producing the same and antiarrythmic agents containing the same
CY1955A (en) Immunomodulatory azaspiranes
AU3292789A (en) Platinum(ii) complexes, their preparation and use as anti-tumour agents
ZA891241B (en) Therapeutic agents for the treatment of peptic ulcer disease
DE3362504D1 (en) 1-carboxyalkanoylindoline-2-carboxylic-acid esters, their preparation, pharmaceutical compositions containing them, and their therapeutic use
IL89908A0 (en) 2-alkyl-3-benzoylbenzofurans and pharmaceutical compositions containing them
ES2046641T3 (es) Composicion antitumoral.
GB8706662D0 (en) Anti-arrhythmia agents
ZA907639B (en) Benzanilides
GR3007219T3 (el)
ZA906446B (en) Therapeutic agents for the treatment of peptic ulcer disease
IL90942A0 (en) Topical pharmaceutical compositions containing retinoids